|
SPC24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55431223447522E-15 |
| Normal-vs-Stage2 |
4.812000E-04 |
| Normal-vs-Stage3 |
1.67169944553791E-10 |
| Normal-vs-Stage4 |
1.02089999998167E-06 |
| Stage1-vs-Stage2 |
9.852400E-01 |
| Stage1-vs-Stage3 |
8.637600E-02 |
| Stage1-vs-Stage4 |
3.397000E-03 |
| Stage2-vs-Stage3 |
2.947200E-01 |
| Stage2-vs-Stage4 |
8.696700E-03 |
| Stage3-vs-Stage4 |
3.164300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.91459999976784E-07 |
| Normal-vs-Asian |
1.527210E-01 |
| Caucasian-vs-AfricanAmerican |
4.922200E-02 |
| Caucasian-vs-Asian |
4.103800E-01 |
| AfricanAmerican-vs-Asian |
3.146200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.66133814775094E-16 |
| Normal-vs-Female |
1.70752301187349E-13 |
| Male-vs-Female |
5.677600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.604000E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
7.02826685738955E-12 |
| Normal-vs-Age(81-100Yrs) |
4.255200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.652800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.366000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.038400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.297830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.638800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.682640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.30499999995148E-06 |
| Normal-vs-Grade 2 |
1.30784272300843E-13 |
| Normal-vs-Grade 3 |
1.62458935193399E-12 |
| Normal-vs-Grade 4 |
1.66204999999531E-05 |
| Grade 1-vs-Grade 2 |
6.436000E-01 |
| Grade 1-vs-Grade 3 |
5.645200E-01 |
| Grade 1-vs-Grade 4 |
1.426170E-02 |
| Grade 2-vs-Grade 3 |
2.780300E-02 |
| Grade 2-vs-Grade 4 |
4.017100E-03 |
| Grade 3-vs-Grade 4 |
1.927600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.2906793369707E-12 |
| Normal-vs-ccB subtype |
1.80799997195891E-09 |
| ccA subtype-vs-ccB subtype |
1.742560E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62481139653892E-12 |
| Normal-vs-N1 |
1.023620E-03 |
| N0-vs-N1 |
2.319800E-02 |
|
|
